Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention

Autor: Yi‐Long Wu, Shun Lu, Ying Cheng, Qing Zhou, Hai‐Yan Tu, Qing‐Hua Zhou, Lv‐Hua Wang, Li Zhang, Jian‐Ying Zhou, Cheng Huang, Ming Chen, Cheng‐Ping Hu, Shao‐Kun Chuai, Xiao‐Nan Wang, Xiao‐Qing Liu, Ji‐Wei Liu, Peng‐Hui Zhou, Wei‐Zhi Chen, Ling‐Hua Yan, Yun‐Peng Liu, An‐Wen Liu, Xu‐Chao Zhang, Hui Li, Rong‐Rong Chen, Dong‐Mei Lin, Cong‐Ying Xie, Zheng‐Fei Zhu, Hui‐Ying Liang, Yong Song, Xiao‐Rong Dong, Ming‐Fang Zhao, Gui‐Bin Qiao, Jiu‐Wei Cui, Zi‐Ming Li, Zhi‐Jie Wang, Xiao‐Yuan Chen, Nong Yang, Gen Lin, Pan‐Wen Tian, Yun Fan, Qi‐Bin Song, Yuan Chen, Jian‐Chun Duan, Jia‐Lei Wang, Bo Zhu, Bu‐Hai Wang, Jun Zhao, Qi‐Tao Yu, Li‐Feng Wang, Hai‐Bo Zhang, Jie Hu, Rui Ma, Tong‐Mei Zhang, Jie Lin, Qian Chu, Sheng‐Xiang Ren, Yu Yao, Lin Wu, Hui‐Juan Wang, Fang Wu, Wen‐Zhao Zhong, Yi Hu, Ke‐Neng Chen, Jian Zhao, Fan Yang, Qun Wang, Dong‐Sheng Yue, Jian‐Ya Zhou, Peng Shen, Jia‐Tao Zhang, Xiao‐Long Yan, Mei‐Juan Huang, Wei‐Neng Feng, Li Li, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG)

Publikováno v: Medicine Advances, Vol 1, Iss 4, Pp 293-305 (2023)

Abstract The importance of uncommon/rare oncogenic drivers in non‐small cell lung cancer (NSCLC) was underscored during the 20th China Lung Cancer Summit. These drivers, while present in a significant proportion of NSCLC patients, remain a challeng

Externí odkaz: https://doaj.org/article/6cf86ef452334af4a74e37fd66750545

Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations

Autor: Meng Li, Li Zhang, Wei Tang, Jian-Chun Duan, Yu-Jing Jin, Lin-Lin Qi, Ning Wu

Publikováno v: Cancer Imaging, Vol 19, Iss 1, Pp 1-11 (2019)

Abstract Background Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal growth factor receptor (EGFR) are the two most frequent and well-known oncogene of lung adenocarcinoma. The purpose of this study is to compare the characteristics me

Externí odkaz: https://doaj.org/article/3de9ec47656940eb978f3566fc1a2fe0

Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations

Autor: Yu-Jing Jin, Jian-Chun Duan, Ning Wu, Meng Li, Li Zhang, Linlin Qi, Wei Tang

Publikováno v: Cancer Imaging, Vol 19, Iss 1, Pp 1-11 (2019)
Cancer Imaging

Background Kirsten rat sarcoma viral oncogene homolog (KRAS) and epidermal growth factor receptor (EGFR) are the two most frequent and well-known oncogene of lung adenocarcinoma. The purpose of this study is to compare the characteristics measured wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3306cd3e2352a1311c95438a8fdd994b
https://doaj.org/article/3de9ec47656940eb978f3566fc1a2fe0

Analysis of BIM (BCL-2 like 11 gene) deletion polymorphism in Chinese non-small cell lung cancer patients

Autor: Jia, Zhong, Zheng-Xiang, Li, Jun, Zhao, Jian-Chun, Duan, Hua, Bai, Tong-Tong, An, Xiao-Dan, Yang, Jie, Wang

Publikováno v: Thoracic cancer. 5(6)

Drug resistance significantly weakens the efficacy of cancer treatment, and the BIM (also known as the BCL2L11 gene) deletion polymorphism has been identified as a potential biomarker for drug resistance. In this retrospective study, we included a to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::67b1cd4395f47c22fd4564a991943858
https://pubmed.ncbi.nlm.nih.gov/26767045

[Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer]

Autor: Jian-chun, Duan, Tong-tong, An, Mei-na, Wu, Lu, Yang, Hua, Bai, Zhi-jie, Wang, Yu-yan, Wang, Ming-lei, Zhuo, Jun, Zhao, Shu-hang, Wang, Jie, Wang

Publikováno v: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. 35(5)

To investigate the frequency of epidermal growth factor receptor (EGFR) mutations and their correlation with the efficacy of tyrosine kinase inhibitors (EGFR-TKI) in advanced squamous cell lung cancer.This retrospective study enrolled 79 patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6d226f73a6bc991f44e64ee0448d2ed7
https://pubmed.ncbi.nlm.nih.gov/22883988